ANA HARWOOD: Open Payments
NPI 1376735563 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 14 payments from 7 companies in 2025. Trend: 2023 $846 · 2024 $6,189 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Janssen Biotech, Inc. | 2 | $53 |
| Astellas Pharma US Inc | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Caris MPI, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: Lenvima, PLUVICTO, ERLEADA, Xtandi, Nubeqa, MI CANCER SEEK.
Industry payments across FL — which companies pay providers there.
